Skip to content
Companies

Biophy

AI that predicts clinical trial outcomes

Raised to date

$6.6M

of $6.6M offered across 1 Form D filing

Investors
56
Last filed
Mar 20, 2025

About

BioPhy, Inc. is a pioneering healthcare technology firm specializing in the application of artificial intelligence to transform drug development processes. By leveraging advanced AI solutions, the company aims to substantially reduce the inefficiencies and costs traditionally associated with bringing new pharmaceutical products to market.

BioPhy stands out for its ability to predict clinical trial outcomes with over 80% accuracy, which significantly reduces both the time and resources spent on drug development.

Funding

  • EquityFiled Mar 20, 2025Form D
    $6.6M/ $6.6M

Product

BioLogicAI

Predictive Analytics

BioLogicAI is an advanced predictive AI engine designed to analyze extensive clinical trial data, thereby forecasting study outcomes and optimizing decision-making in drug development. The platform evaluates the biological feasibility of prospective drug candidates and predicts their potential success in clinical trials.

  • Predictive analytics for clinical trial outcomes
  • Assessment of biological feasibility of drug candidates
  • Optimization of development decisions

Built for

Pharmaceutical and biotechnology firms

People on file